MARVELD2 and breast cancer: As(III) was shown to bind to individual members of the human TRiC/CCT complex using a human proteome microarray [181] as well as to actin and tubulin in human lymphoblastoid cells and human breast cancer cells [145, 154] that are major TRiC/CCT substrates.